Evidence map›Paper›PMID 37702516›Full record

ArticleAntimicrobial agents and chemotherapy2023

Amuza Byaruhanga Lucky, Chengqi Wang, Ahmad Rushdi Shakri, Mohammad Kalamuddin, Anongruk Chim-Ong, Xiaolian Li, Jun Miao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

  • Update of
    2023
5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amuza Byaruhanga Lucky *Department of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
Chengqi Wang *Center for Global Health and Infectious Diseases Research, College of Public Health, University of South Florida , Tampa, Florida, USA.
Ahmad Rushdi Shakri *Department of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
Mohammad KalamuddinDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
Anongruk Chim-OngDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
Xiaolian LiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.
Jun MiaoDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida , Tampa, Florida, USA.ORCID 0000-0001-9374-6749
University of South Florida · US

Funding

Development of CRISPR/dCas-based epigenetic gene regulation tools in malaria parasiteR21AI149202 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI MIAO, JUN · 2020 to 2021
$411k
NIAID NIH HHS R21 AI149202
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsArtemisininsMalaria, FalciparumDrug ResistanceGlucoseHumansPlasmodium falciparumProtozoan ProteinsAntimalarialsartemisininArtemisininsGlucoseProtozoan Proteinsartemisinin resistanceGCN5malariaPlasmodium falciparumstress response

Identifiers

PMID37702516
PMCPMC10583690
OpenAlexW4386705502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.